ChatGPT for Science the IA that reaches science with restricted doors and its impact on open research

OpenAI is testing a new science-oriented offer that, for now, appears on pages and in catches, but it remains unclear whether it will be available to any researcher or whether it will be restricted to verified institutions. As found on the web and social network X, the provisional name is ChatGPT for Science, and its launch seems imminent in terms of evidence, although the company has not yet published an official date and access criteria.

The most relevant antecedent is GPT-Rosalind, a model designed for life science research and presented by OpenAI as a high-performance solution designed for entities with robust infrastructure and governance. GPT-Rosalind works under what the company calls a "trusted-access deployment structure", that is, a deployment with strict controls and limited access to eligible organisations - an approach that prioritizes security and compliance but reduces the democratization of access. More official details on this initiative are available on the OpenAI website: https: / / openai.com / index / introng-new-capabilities-to-gpt-rosalind /.

If ChatGPT for Science replicates that restriction model, the consequences are double. On the one hand, promotes double-use risk mitigation(e.g. generation of dangerous instructions in biosecurity or design of harmful agents), by ensuring that only entities with internal policies and technical controls access sensitive capabilities. On the other hand, it can produce unwanted effects on open research: small groups, universities in countries with less resources and independent laboratories could be left out of tools that accelerate discoveries, thus widening the technological gap between actors with and without access.

The behaviour observed in public tests suggests that OpenAI values traceability and safety, similar to its Enterprise model, which requires identity controls and specific contracts for customers. These signals invite us to anticipate that ChatGPT for Science will have institutional verification requirements and governance agreements. The X-post that reported the early appearance of the service can be found here: https: / / x.com / testingcatalog / status / 2067265595591016523.

For the scientific community and policy makers, this poses urgent decisions. Institutes should prepare governance frameworks, risk assessments and acceptable use policies before hiring or integrating these services: define which projects the model is used for, who has access to the keys, how interactions are recorded and what limits apply to sensitive data. IT security units must require end-to-end encryption, audit records and third-party reviews on the robustness of access control.

From the perspective of open research, funding agencies and magazines can call for transparency on which tools were used in scientific work and require reproducible verification protocols. If access is to be conditional on "verified" entities, it is reasonable to promote mechanisms that allow small universities and centres in developing countries to access through consortia, subsidies or multilateral agreements that avoid concentrating capacities only on large pharmaceutical companies or technology companies.

Finally, for those working in cybersecurity and risk management, the arrival of specialized science services is a reminder that technical barriers are not enough: operational controls, abuse simulations and continuous audits must be implemented. The recommended practice is to integrate these platforms into segmented environments, monitor outputs and apply distance between identifiable data and training or inference systems. Institutions with an interest in assessing alternatives should also study open source models and community platforms that offer greater local control, in parallel to commercial solutions.

The likely appearance of ChatGPT for Science announces a stage in which artificial intelligence specializes by domain and is marketed with access conditions aligned to real risks. The scientific community, security officials and regulators now have the opportunity to define standards of access, transparency and redistribution of capacities for technology to drive public research without compromising biosafety and global equity.